Get Stock Market Tips, Commodity Tips and more click here to get your offers @@ http://www.ripplesadvisory.com
Leading drug maker Cipla Ltd on Friday reported Rs 409 crore consolidated net profit for the first quarter of 2017-18, registering 21 per cent growth from Rs 339 crore in the same period year ago.
In a regulatory filing to the BSE, the pharma major said consolidated income from operations for Q1, declined annually 3.4 per cent to Rs 3,525 crore from Rs 3,650 crore in the like period year ago.
Sequentially, it posted a consolidated net loss of Rs 62 crore in the previous quarter on consolidated revenue of Rs 3,582 crore, which is 1.6 per cent lower.
"Ebitda (earnings before income tax, depreciation, and amortization) grew 5.7 per cent annually to Rs 646 crore in Q1 from Rs 611 crore the year ago and 28 per cent up sequentially from Rs 506 crore in the last quarter," it said in the filing.
The company has invested Rs 212 crore on research and development and generated Rs 108 crore cash from operations during the quarter.
No comments:
Post a Comment